Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 23 August 2005. doi:10.1136/gut.2004.063008
Gut 2006;55:220-227
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
gut.2004.063008v1
55/2/220    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Middel, P
Right arrow Articles by Radzun, H-J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Middel, P
Right arrow Articles by Radzun, H-J
Topic Collections
Right arrowRelevant Article

INFLAMMATORY BOWEL DISEASE

Increased number of mature dendritic cells in Crohn’s disease: evidence for a chemokine mediated retention mechanism

P Middel1, D Raddatz2, B Gunawan1, F Haller1, H-J Radzun1

1 Department of Pathology, Georg-August University of Göttingen, Göttingen, Germany
2 Department of Gastroenterology, Georg-August University of Göttingen, Göttingen, Germany

Correspondence to:
Correspondence to:
Dr P Middel
Zentrum Pathologie, Georg-August-Universität Göttingen, Robert-Koch-Str 40, 37073 Göttingen, Germany; pmiddel{at}med.uni-goettingen.de

Background and aims: Activation of T cells by dendritic cells (DC) is thought to play a pivotal role in induction and maintenance of Crohn’s disease. Detailed analyses however concerning the phenotype and maturation of DC as well as the mechanisms underlying their recruitment are still lacking for Crohn’s disease.

Methods: Different myeloid and plasmacytoid DC subsets were characterised by immunohistochemistry. Expression of the so-called "lymphoid" chemokines CCL19, CCL20, and CCL21 was determined by real time reverse transcription-polymerase chain reaction in Crohn’s disease and normal controls. Furthermore, expression of CCL19, CCL20, and CCL21 as well as their receptors CCR6 (for CCL20) and CCR7 (for CCL19 and CCL21) was characterised by immunohistochemistry and, in addition, their cellular localisation was determined by double immunofluorescence investigations.

Results: Colonic tissue affected by Crohn’s disease was characterised by an increased number of mature myeloid DC forming clusters with proliferating T cells. In keeping with their advanced maturation, DC possess the chemokine receptor CCR7. Increased expression of the CCR7 ligands CCL19 by DC themselves as well as CCL21 by reticular cells and lymphatic vessels was observed in Crohn’s disease, thereby causing the matured DC to be trapped at the site of inflammation.

Conclusion: Our results demonstrate that autocrine and paracrine actions of lymphoid chemokines in Crohn’s disease may lead to increased numbers of mature DC away from their usual migration to lymphoid organs and result in the development of a tertiary lymphatic tissue within the bowel wall maintaining the autoimmune inflammation in Crohn’s disease.


Abbreviations: CD, Crohn’s disease; DC, dendritic cells; NIGD, non-inflammatory gut disorder; RT-PCR, reverse transcription-polymerase chain reaction; Cy2, indocarbocyanine 2; Cy3, indocarbocyanine 3; CARD15, caspase activating and recruitment domain 15

Keywords: Crohn’s disease; chemokines; dendritic cells


Relevant Article

Digest
Robin Spiller and Alistair Watson
Gut 2006 55: 141. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Immunol.Home page
A. De Filippo, R. J. Binder, C. Camisaschi, V. Beretta, F. Arienti, A. Villa, P. Della Mina, G. Parmiani, L. Rivoltini, and C. Castelli
Human Plasmacytoid Dendritic Cells Interact with gp96 via CD91 and Regulate Inflammatory Responses
J. Immunol., November 1, 2008; 181(9): 6525 - 6535.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Byers, P. A. Calloway, L. Shannon, H. D. Cunningham, S. Smith, F. Li, B. C. Fassold, and C. M. Vines
Arrestin 3 Mediates Endocytosis of CCR7 following Ligation of CCL19 but Not CCL21
J. Immunol., October 1, 2008; 181(7): 4723 - 4732.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
M. I. Verstege, F. J.W. ten Kate, S. M. Reinartz, C. M. van Drunen, F. J.M. Slors, W. A. Bemelman, F. A. Vyth-Dreese, and A. A. te Velde
Dendritic Cell Populations in Colon and Mesenteric Lymph Nodes of Patients With Crohn's Disease
J. Histochem. Cytochem., March 1, 2008; 56(3): 233 - 241.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
R. K. Reeves and P. N. Fultz
Characterization of Plasmacytoid Dendritic Cells in Bone Marrow of Pig-Tailed Macaques
Clin. Vaccine Immunol., January 1, 2008; 15(1): 35 - 41.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Manzo, S. Bugatti, R. Caporali, R. Prevo, D. G. Jackson, M. Uguccioni, C. D. Buckley, C. Montecucco, and C. Pitzalis
CCL21 Expression Pattern of Human Secondary Lymphoid Organ Stroma Is Conserved in Inflammatory Lesions with Lymphoid Neogenesis
Am. J. Pathol., November 1, 2007; 171(5): 1549 - 1562.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. John and P. J. Nelson
Dendritic Cells in the Kidney
J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2628 - 2635.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. C. Furtado, T. Marinkovic, A. P. Martin, A. Garin, B. Hoch, W. Hubner, B. K. Chen, E. Genden, M. Skobe, and S. A. Lira
Lymphotoxin beta receptor signaling is required for inflammatory lymphangiogenesis in the thyroid
PNAS, March 20, 2007; 104(12): 5026 - 5031.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. K. Damas, C. Smith, E. Oie, B. Fevang, B. Halvorsen, T. Waehre, A. Boullier, U. Breland, A. Yndestad, O. Ovchinnikova, et al.
Enhanced Expression of the Homeostatic Chemokines CCL19 and CCL21 in Clinical and Experimental Atherosclerosis: Possible Pathogenic Role in Plaque Destabilization
Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 614 - 620.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology